Observed Signal · Oct 28, 2026 · corporate_event · Source: SEC API · Impact: 3/5

6-K Financial Filing Analysis for KNOREX (2026-10-28)

Executive Signal Summary

Knorex Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on October 28, 2026, furnishing its unaudited condensed consolidated financial statements and operating and financial review for the six months ended June 30, 2026, and 2025. The filing serves as the company's semi-annual financial disclosure required for foreign private issuers, incorporating interim financial results in Exhibit 99.1 and accompanying management commentary in Exhibit 99.2.

Polaris7 AgentPolaris7 Strategic Assessment
High Confidence

Furnishing semi-annual interim financial results is a critical compliance requirement that provides investors with updated visibility into Knorex's operational performance and financial position for H1 2026.

SIGNAL RADAR

Track KNOREX Signals & Market Shifts in Real-Time

Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.

Start Monitoring
Verified primary sourcesAutomated briefingsInstant watchlist setup

Key Takeaways & Evidence Grounding

  • Knorex furnished unaudited condensed consolidated financial statements and management review for the six-month period ended June 30, 2026, and June 30, 2025, via Exhibits 99.1 and 99.2.
  • The filing was authorized and signed by Khar Heng Choo, Chairman of the Board of Directors and Chief Executive Officer, on October 27, 2026.
  • The report satisfies foreign private issuer reporting obligations under the Securities Exchange Act of 1934 on Form 6-K.
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: SEC API•Published: Oct 28, 2026

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

financialsAug 26, 2026

6-K Financial Filing Analysis for KNOREX (2026-08-26)

On August 21, 2026, KNOREX Ltd. received a deficiency notice from NYSE Regulation regarding non-compliance with NYSE American continued listing standards under Sections 1003(a)(i) and 1003(a)(ii). The non-compliance stems from consecutive net losses over the last four fiscal years and a stockholders' deficit of $(6.5) million as of December 31, 2025, against minimum stockholders' equity requirements of $2.0 million to $4.0 million. The company plans to submit a compliance plan by September 20, 2026, seeking to regain compliance by February 21, 2028, during which its Class A ordinary shares will continue trading normally subject to NYSE acceptance and progress milestones.

Read assessment
financialsAug 19, 2026

20-F Financial Filing Analysis for KNOREX (2026-08-19)

KNOREX LTD. filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, reporting total revenue of approximately $6.04 million, representing a 44% year-over-year decline compared to $10.81 million in FY2024. The contraction was primarily driven by a substantial spending reduction from its largest customer (whose revenue contribution fell from 73.3% in FY2024 to 40.6% in FY2025) after that customer's key client was impacted by increased U.S. import tariffs. Gross profit declined from $4.5 million in 2024 to $2.9 million in 2025, while active customer count fell to 26 from 37 amid customer portfolio realignments. The company incurred a working capital deficit of $7.7 million, raising substantial doubt about its ability to continue as a going concern, though it secured a post-period $3.0 million note financing and an up to $50.0 million share purchase facility in March 2026.

Read assessment
financialsNov 4, 2026

6-K Financial Filing Analysis for Thomson Reuters (2026-11-04)

Thomson Reuters Corporation submitted its Form 6-K filing for November 2026, furnishing its Q3 2026 interim financial report for the period ending September 30, 2026. The filing serves as the formal transmittal vehicle for the company's interim Management's Discussion and Analysis (Exhibit 99.1) and Unaudited Consolidated Financial Statements (Exhibit 99.2). Additionally, the submission incorporates voluntary executive certifications by the Chief Executive Officer and Chief Financial Officer under Sections 302 and 906 of the Sarbanes-Oxley Act of 2002.

Read assessment
Executive Briefing & Watchlist

Receive all future signals for KNOREX & competitors in your briefing

Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.

Daily primary source scansCurated executive briefingsUnsubscribe anytime